|Chris Lee is Site Head of Singapore for WuXi Biologics since Sep 2021.  Prior to joining WuXi Biologics, Chris has 24 years of work experience in both technical and commercial operations roles. His previous employers include Lonza Biologics China, Johnson & Johnson Medical Device Asia Pacific, Merck Sharpe Dohme (MSD) China and Asia Pacific, Becton Dickinson Asia Pacific and China, and Schering Plough Singapore and Asia Pacific. He was based in Guangzhou for 2 years, Shanghai for 6 years, Hong Kong for 1 year for his international work assignments. Prior to joining the industry, Chris worked for the Singapore Economic Development Board to promote the development of the biotechnology and pharmaceutical ecosystem in Singapore.   Chris holds a B.Eng. (First Class) in Chemical Engineering from University of Manchester Institute of Science and Technology (Manchester, UK), a M.S.  in Chemical Engineering from Stanford University (California, US) and an MBA from University of Chicago – Booth School of Business (Illinois, US).